JP2010509937A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509937A5 JP2010509937A5 JP2009538451A JP2009538451A JP2010509937A5 JP 2010509937 A5 JP2010509937 A5 JP 2010509937A5 JP 2009538451 A JP2009538451 A JP 2009538451A JP 2009538451 A JP2009538451 A JP 2009538451A JP 2010509937 A5 JP2010509937 A5 JP 2010509937A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- antigen
- variable region
- cell line
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/562,759 US7488807B2 (en) | 2006-11-22 | 2006-11-22 | Antibody with protein A selectivity |
| PCT/US2007/084736 WO2008140570A2 (en) | 2006-11-22 | 2007-11-15 | Antibody with protein a selectivity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010509937A JP2010509937A (ja) | 2010-04-02 |
| JP2010509937A5 true JP2010509937A5 (https=) | 2011-01-06 |
Family
ID=39417386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009538451A Withdrawn JP2010509937A (ja) | 2006-11-22 | 2007-11-15 | プロテインａ選択性を有する抗体 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US7488807B2 (https=) |
| EP (1) | EP2087003A2 (https=) |
| JP (1) | JP2010509937A (https=) |
| WO (1) | WO2008140570A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100062418A1 (en) * | 2006-11-22 | 2010-03-11 | Mach Patrick A | Inactivated and dried biological preparations |
| US20100099115A1 (en) | 2006-11-22 | 2010-04-22 | Mach Patrick A | Systems and methods for preparing and analyzing samples |
| EP2137533A2 (en) * | 2007-04-19 | 2009-12-30 | 3M Innovative Properties Company | Uses of water-dispersible silica nanoparticles for attaching biomolecules |
| WO2008131063A1 (en) * | 2007-04-19 | 2008-10-30 | 3M Innovative Properties Company | Methods of use of solid support material for binding biomolecules |
| CN101918842A (zh) * | 2007-11-20 | 2010-12-15 | 3M创新有限公司 | 利用含二乙炔的聚合物传感器分析细菌样品的方法 |
| ES2784957T3 (es) | 2009-04-03 | 2020-10-02 | Univ Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SPA) |
| JP6002128B2 (ja) | 2010-07-02 | 2016-10-05 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | プロテインＡ（ＳｐＡ）変種に関連する組成物および方法 |
| BR112014003315A2 (pt) | 2011-08-15 | 2017-03-01 | Univ Chicago | composições e métodos relacionados a anticorpos para a proteína a estafilocócica |
| US9988439B2 (en) | 2011-12-23 | 2018-06-05 | Nicholas B. Lydon | Immunoglobulins and variants directed against pathogenic microbes |
| WO2013096948A1 (en) | 2011-12-23 | 2013-06-27 | Lydon Nicholas B | Immunoglobulins and variants directed against pathogenic microbes |
| KR101753553B1 (ko) | 2014-06-03 | 2017-07-03 | 엑스바이오테크, 인크. | 스타필로코커스 아우레우스 감염의 치료 및 예방을 위한 조성물 및 방법 |
| BR112021005522A2 (pt) * | 2018-11-21 | 2021-06-29 | Regeneron Pharmaceuticals, Inc. | anticorpo isolado ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica, molécula polinucleotídica isolada, vetor, célula, e, métodos de prevenção, tratamento ou melhoria de infecção por s. aureus, uma condição causada por infecção por s. aureus, ou pelo menos um sintoma de infecção por s. aureus, ou de diminuir a frequência ou gravidade de infecção por s. aureus, uma condição causada por infecção por s. aureus, de pelo menos um sintoma de infecção por s. aureus, para prevenir uma infecção por s. aureus, de prevenção, tratamento ou melhoria de infecção por s. aureus, ou de diminuir a frequência ou gravidade de infecção por s. aureus, em um indivíduo com um cateter, uma articulação protética ou qualquer outro objeto estranho, para prevenir, tratar ou melhorar a infecção estafilocócica, ou para diminuir a frequência ou gravidade da infecção estafilócica |
| MX2021013833A (es) | 2019-05-14 | 2022-03-17 | Univ Chicago | Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa). |
| WO2021051136A1 (en) | 2019-09-13 | 2021-03-18 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| GB8426463D0 (en) | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
| JPS63273495A (ja) | 1987-04-30 | 1988-11-10 | Sekisui Chem Co Ltd | 抗プロテインａ単クロ−ン性抗体とその製法，および該抗体を用いるプロテインａの測定方法 |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP0436597B1 (en) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| EP0585287B1 (en) | 1990-07-10 | 1999-10-13 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
| EP0575485A1 (en) | 1991-03-01 | 1993-12-29 | Dyax Corp. | Process for the development of binding mini-proteins |
| DK0580737T3 (da) | 1991-04-10 | 2004-11-01 | Scripps Research Inst | Heterodimere receptorbiblioteker ved anvendelse af phagemider |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| US6994855B1 (en) | 1994-08-22 | 2006-02-07 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| US5594116A (en) | 1995-11-08 | 1997-01-14 | Promega Corporation | Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| FR2746398B1 (fr) | 1996-03-21 | 1998-04-30 | Bio Merieux | Anticorps specifique de staphylococcus aureaus, et utilisations |
| JP4424984B2 (ja) | 2001-06-15 | 2010-03-03 | インヒビテックス インコーポレーテッド | コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体 |
| WO2003059935A2 (en) | 2001-12-21 | 2003-07-24 | Immunex Corporation | Methods for purifying protein |
| AU2003284643A1 (en) | 2002-11-22 | 2004-06-18 | Daiichi Pure Chemicals Co., Ltd. | Method of examining staphylococcus aureus |
| WO2008064232A2 (en) * | 2006-11-22 | 2008-05-29 | 3M Innovative Properties Company | Fluidic antibody-containing devices and methods |
-
2006
- 2006-11-22 US US11/562,759 patent/US7488807B2/en not_active Expired - Fee Related
-
2007
- 2007-11-15 EP EP07874277A patent/EP2087003A2/en not_active Withdrawn
- 2007-11-15 JP JP2009538451A patent/JP2010509937A/ja not_active Withdrawn
- 2007-11-15 WO PCT/US2007/084736 patent/WO2008140570A2/en not_active Ceased
-
2009
- 2009-01-20 US US12/356,241 patent/US20090162902A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010509937A5 (https=) | ||
| JP2010513228A5 (https=) | ||
| HRP20201634T1 (hr) | Monoklonsko protutijelo protiv interleukina-31 | |
| CA2953714C (en) | Anti-tnfa antibodies with ph-dependent antigen binding | |
| JP2013198490A5 (https=) | ||
| PE20110801A1 (es) | Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f | |
| NZ595464A (en) | Alpha-4-beta-7 heterodimer specific antagonist antibody | |
| NZ597023A (en) | Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same | |
| WO2013037484A8 (en) | ANTI-αβTCR ANTIBODY | |
| JP2015028021A5 (https=) | ||
| FI3683235T3 (fi) | Anti-IL-33-vasta-aineita ja niiden käyttöjä | |
| NO20074867L (no) | Antistoffer mot CCR5 og anvendelser derav | |
| EA201190132A1 (ru) | Гуманизированные антитела, связывающиеся с cd19, и их применение | |
| ES2572231T3 (es) | Anticuerpos monoclonales anti-IL-21 humana | |
| NZ623706A (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof | |
| RU2017128882A (ru) | Антитела к биотину и способы их применения | |
| WO2008143697A3 (en) | Antibody with protein a selectivity | |
| RU2014100111A (ru) | МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Psl Pseudomonas, И ПУТИ ИХ ПРИМЕНЕНИЯ | |
| HRP20140266T1 (hr) | Postupci inhibiranja vezanja endosijalina na ligande | |
| EA201990673A1 (ru) | Антитела, специфически связывающиеся с il-17a, и их функциональные фрагменты | |
| WO2008140570A3 (en) | Antibody with protein a selectivity | |
| JP2016516400A5 (https=) | ||
| JP2017518260A5 (https=) | ||
| JP2018507254A5 (https=) | ||
| MX2016004928A (es) | Secuencias de anticuerpos con reaccion cruzada para staphylococcus aureus. |